Considering that none of the recruited children in our cohort presented with T2DM, we hypothesize that the higher levels of adipsin observed in the obese and MS groups compared with the normal weight group might indicate a compensatory mechanism to increase glucose tolerance in the context of childhood obesity and to possibly delay the onset of T2DM. The gene discussed is CFD; the disease is myeloid sarcoma.